14 | CopperIBA
03/2024
-
04/2008 |
9 | Antineoplastic Agents (Antineoplastics)IBA
01/2022
-
02/2008 |
8 | casiopeina II-glycineIBA
01/2021
-
09/2006 |
7 | Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024
-
04/2012 |
5 | (4,4- dimethyl- 2,2- bipyridine)(acetylacetonate)copper(II)IBA
03/2024
-
09/2007 |
4 | Cisplatin (Platino)FDA LinkGeneric
02/2022
-
06/2011 |
4 | Metronidazole (Metric)FDA LinkGeneric
03/2020
-
09/2012 |
3 | (Cu(4,4'- dimethyl- 2,2'- bipyridine)(glycinato)(H2O))NO3IBA
02/2022
-
09/2013 |
3 | MetalsIBA
01/2022
-
09/2012 |
3 | (Cu(4,7- dimethyl- 1,10- phenanthroline)(acetylacetonato)(H2O))NO3IBA
01/2017
-
09/2013 |
2 | Caspase 3 (Caspase-3)IBA
02/2022
-
07/2019 |
2 | Glutathione (Reduced Glutathione)IBA
09/2021
-
06/2011 |
2 | DNA (Deoxyribonucleic Acid)IBA
04/2012
-
07/2007 |
1 | Free RadicalsIBA
03/2024 |
1 | lissamine rhodamine B (sulforhodamine B)IBA
05/2022 |
1 | CalciumIBA
02/2022 |
1 | AntioxidantsIBA
09/2021 |
1 | CateninsIBA
01/2021 |
1 | Cytochromes c (Cytochrome c)IBA
07/2019 |
1 | bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
07/2019 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 |
1 | Human Serum AlbuminFDA LinkGeneric
10/2017 |
1 | Proteins (Proteins, Gene)FDA Link
10/2017 |
1 | Anticarcinogenic AgentsIBA
01/2017 |
1 | Sulfhydryl Compounds (Thiols)IBA
02/2016 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2016 |
1 | 2,2'-Dipyridyl (2,2 Bipyridine)IBA
09/2013 |
1 | PhenanthrolinesIBA
09/2013 |
1 | LigandsIBA
09/2012 |
1 | IonsIBA
09/2012 |
1 | Coordination ComplexesIBA
07/2007 |
1 | LipidsIBA
07/2007 |
1 | Adenosine Triphosphate (ATP)IBA
09/2006 |
1 | RhodaminesIBA
09/2006 |
1 | OligomycinsIBA
09/2006 |
1 | arseniteIBA
09/2006 |
1 | GossypolIBA
09/2006 |
1 | Glutamine (L-Glutamine)FDA Link
09/2006 |
1 | Glucose (Dextrose)FDA LinkGeneric
09/2006 |